Alkem Laboratories Limited Alkem Laboratories Limited

Alkem Laboratories Limited

ALKEM

Rang in Aktien #2815
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aktienkurs
$55.19
Marktkapitalisierung
$6.60B
Veränderung (1 Tag)
-0.06%
Veränderung (1 Jahr)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)

Kategorie

Healthcare
Aktien-Split-Historie für Alkem Laboratories Limited (ALKEM)
Die Aktie Alkem Laboratories Limited (Symbol: ALKEM) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine ALKEM-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 ALKEM-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber